Nonparametric Estimation from Incomplete Observations

By E. Kaplan, P. Meier. 1958

Abstract In lifetesting, medical follow-up, and other fields the observation of the time of occurrence of the event of interest (called a death) may be prevented for some of the items of the sample by the previous occurrence of some other event (called a loss). Losses may be either accidental or controlled, the latter resulting from a decision to terminate certain observations. In either case it is usually assumed in this paper that the lifetime (age at death) is independent of the potential loss time; in practice this assumption deserves careful scrutiny. Despite the resulting incompleteness of the data, it is desired to estimate the proportion P(t) of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t). The observation for each item of a suitable initial event, marking the beginning of its lifetime, is presupposed. For random samples of size N the product-limit (PL) estimate can be defined as follows: L...

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Opportunities and obstacles for deep learning in biology and medicine (2017, background): “This results in loss of information as timing and order of events can provide insight into a patient's disease and treatment [135].”
Mining Electronic Health Records: A Survey (2017, methodology): “Examples of such techniques include Kaplan-Meier estimators [Kaplan and Meier 1958] and Nelson-Aalen estimators [Cox 1992].”
A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. (2003, background): “52 Family composition Spousal 19 (61) 37 (53) .”
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. (2003, methodology): “Event-free survival and overall survival was estimated using the Kaplan-Meier method and the differences among mutation groups were compared using a log-rank test.(26) For the event-free survival analysis, end point clinical events were defined as PD, patient death from any cause, withdrawal of pati”
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma (2002, unknown): “038 6 Months 24 14 (11-24) 13 17 (10-28) .”
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). (2002, background): “6) 65 (20) 12 (60) 7 (35) 6 (30) X 18 (1.”